Annseau 1989a.
Methods | 4 week randomised double blind study. | |
Participants | Diagnosis: Inpatients with RDC major depressive disorder Male and Female. Threshold of baseline severity: MADRS>=25, CGI<=4, Raskin Scale for Depression>Covi Anxiety Scale Total number of all allocated participants: N=146 Age: mean 48.6 (SD 10.8) y, range 20‐70y. |
|
Interventions | Milnacipran 50/100mg: N=97 (50mg: N=47, 100mg: N=48)
Amitriptyline 150mg: N=49 Fixed dosing schedule |
|
Outcomes | Hamilton Depression Rating Scale‐24 item, MADRS,CGI‐I, CGI‐S | |
Notes | Funding: by industry | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "randomly assigned". Probably done. |
Allocation concealment (selection bias) | Unclear risk | Insufficient information. |
Blinding (performance bias and detection bias) All outcomes | Low risk | Quote: "double‐blind". Probably done. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No missing primary outcome data. |
Selective reporting (reporting bias) | High risk | Did not provide number of participants who dropped out during the study due to side effects. |
Other bias | Unclear risk | Insufficient information to assess whether an important risk of bias exists. |